|Mr. Clarence Edward Smith||Chairman, CEO & Pres||N/A||N/A||1964|
|Mr. Michael Richard Guzzetta CPA||Chief Financial Officer||60k||N/A||1958|
|Dr. Jean-Charles Quirion Ph.D.||Head of Researchers for Rouen||N/A||N/A||N/A|
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in food and crop preservation at freezing temperatures. Its AAGPs have commercial applications in the harvesting, storage, and transplantation of cells, tissues, and organs; and treatments for conditions and diseases caused by stress factors, including UV radiation, oxidation, and inflammation. It has collaboration agreement with Proactive Immune Sciences Corporation to test AAGP in immune cell cryopreservation recovery; and a research agreement with the University of British Columbia to test neuronal retinal cells in living tissue for the treatment of macular degeneration. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was founded in 1999 and is based in Marietta, Ohio.
ProtoKinetix, Incorporated’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.